Of note, JQ1 promotes the anti-tumor immunity by reducing the expression of programmed death ligand 1 (PD-L1) [34], an immune checkpoint molecule expressed in NB microenvironment [35]. This evidence concerns the gene CD274 and neuroblastoma.